Deutsch English Français

Contact

EP1852441

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1852441

EP1852441 - Agents that modulate EPH receptor activity [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 01.02.2013 Database last updated on 24.01.2025
Most recent event Tooltip	18.07.2014	Lapse of the patent in a contracting state New state(s): HU	published on 20.08.2014 [2014/34]
Applicant(s)	For all designated states The Burnham Institute 10901 North Torrey Pines Road La Jolla, CA 92037 / US
	[2007/45]
Inventor(s)	01 / Pasquale, Elena B. 6105 Dirac Street San Diego, CA 92122 / US
	02 / Murai, Keith K. 36 De Lacroix Candiac Quebec J5R 6J4 / CA
	03 / Koolpe, Mitchell 5262 Camino Playa Malaga San Diego, CA 92124 / US
	[2007/45]
Representative(s)	Chapman, Paul Gilmour, et al Marks & Clerk LLP The Beacon 176 St Vincent Street Glasgow G2 5SG / GB
	[N/P]
Former [2012/13]	Chapman, Paul Gilmour, et al Marks & Clerk LLP Aurora 120 Bothwell Street Glasgow G2 7JS / GB
Former [2008/33]	Chapman, Paul Gilmour, et al Marks & Clerk 19 Royal Exchange Square Glasgow G1 3AE / GB
Former [2007/45]	Chapman, Paul Gilmour, et al Marks & Clerk 19 Royal Exchange Square Glasgow G1 3AE / GB
Application number, filing date	07007396.0	29.08.2003
	[2007/45]
Priority number, date	US20020413342P	24.09.2002 Original published format: US 413342 P
	[2007/45]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP1852441
	Date:	07.11.2007
	Language:	EN
	[2007/45]
	Type:	A3 Search report
	No.:	EP1852441
	Date:	13.02.2008
	[2008/07]
	Type:	B1 Patent specification
	No.:	EP1852441
	Date:	28.03.2012
	Language:	EN
	[2012/13]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	11.01.2008
Classification	IPC:	C07K14/52, A61K38/19	[2007/45]
	CPC:	C07K14/52 (EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2007/45]
Title	German:	Mittel zur Modulierung der EPH-Rezeptor-Aktivität	[2007/45]
	English:	Agents that modulate EPH receptor activity	[2007/45]
	French:	Agents qui modulent l'activité du récepteur EPH	[2007/45]
Examination procedure	20.04.2007	Examination requested [2007/45]
	27.08.2008	Despatch of a communication from the examining division (Time limit: M06)
	05.03.2009	Reply to a communication from the examining division
	28.12.2009	Despatch of a communication from the examining division (Time limit: M02)
	08.03.2010	Reply to a communication from the examining division
	05.01.2011	Cancellation of oral proceeding that was planned for 04.02.2011
	14.01.2011	Despatch of a communication from the examining division (Time limit: M02)
	04.02.2011	Date of oral proceedings (cancelled)
	24.03.2011	Reply to a communication from the examining division
	01.07.2011	Despatch of communication that the application is refused, reason: formalities examination {1}
	18.10.2011	Communication of intention to grant the patent
	14.02.2012	Fee for grant paid
	14.02.2012	Fee for publishing/printing paid
Appeal following examination	14.07.2011	Appeal received
	14.07.2011	Statement of grounds filed
	06.09.2011	Interlocutory revision of appeal
Parent application(s) Tooltip	EP03749303.8 / EP1553963
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030749303) is 05.12.2006
Opposition(s)	03.01.2013	No opposition filed within time limit [2013/10]
Fees paid	Renewal fee
	20.04.2007	Renewal fee patent year 03
	20.04.2007	Renewal fee patent year 04
	14.08.2007	Renewal fee patent year 05
	14.08.2008	Renewal fee patent year 06
	25.08.2009	Renewal fee patent year 07
	25.08.2010	Renewal fee patent year 08
	25.08.2011	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	29.08.2003
	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	TR	28.03.2012
	BG	28.06.2012
	GR	29.06.2012
	ES	09.07.2012
	PT	30.07.2012
	GB	29.08.2012
	IE	29.08.2012
	LU	29.08.2012
	CH	31.08.2012
	FR	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
	[2014/34]
Former [2014/27]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	TR	28.03.2012
	BG	28.06.2012
	GR	29.06.2012
	ES	09.07.2012
	PT	30.07.2012
	GB	29.08.2012
	IE	29.08.2012
	LU	29.08.2012
	CH	31.08.2012
	FR	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
Former [2014/21]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	TR	28.03.2012
	BG	28.06.2012
	GR	29.06.2012
	ES	09.07.2012
	PT	30.07.2012
	GB	29.08.2012
	IE	29.08.2012
	CH	31.08.2012
	FR	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
Former [2013/40]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	BG	28.06.2012
	GR	29.06.2012
	ES	09.07.2012
	PT	30.07.2012
	GB	29.08.2012
	IE	29.08.2012
	CH	31.08.2012
	FR	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
Former [2013/34]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	BG	28.06.2012
	GR	29.06.2012
	ES	09.07.2012
	PT	30.07.2012
	GB	29.08.2012
	IE	29.08.2012
	CH	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
Former [2013/33]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	BG	28.06.2012
	GR	29.06.2012
	ES	09.07.2012
	PT	30.07.2012
	IE	29.08.2012
	CH	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
Former [2013/22]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
	ES	09.07.2012
	PT	30.07.2012
	CH	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
Former [2013/20]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
	PT	30.07.2012
	CH	31.08.2012
	LI	31.08.2012
	MC	31.08.2012
Former [2013/16]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
	PT	30.07.2012
	MC	31.08.2012
Former [2013/11]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	IT	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
	PT	30.07.2012
Former [2013/08]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	DK	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	NL	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
	PT	30.07.2012
Former [2013/07]	AT	28.03.2012
	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
	PT	30.07.2012
Former [2013/01]	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
	PT	30.07.2012
Former [2012/50]	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	SK	28.03.2012
	GR	29.06.2012
Former [2012/49]	BE	28.03.2012
	CY	28.03.2012
	CZ	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	RO	28.03.2012
	SE	28.03.2012
	SI	28.03.2012
	GR	29.06.2012
Former [2012/48]	BE	28.03.2012
	CY	28.03.2012
	EE	28.03.2012
	FI	28.03.2012
	SE	28.03.2012
	GR	29.06.2012
Former [2012/46]	BE	28.03.2012
	CY	28.03.2012
	FI	28.03.2012
	GR	29.06.2012
Former [2012/41]	CY	28.03.2012
	FI	28.03.2012
	GR	29.06.2012
Former [2012/37]	FI	28.03.2012
	GR	29.06.2012
Former [2012/36]	GR	29.06.2012
Documents cited:	Search	[X]WO0037500 (MOUNT SINAI HOSPITAL CORP [CA], et al) [X] 1-6,8,9 * page 22 - page 23; claims 26,27; sequence 32 *;
		[X]WO9945121 (US HEALTH [US], et al) [X] 1-6,8,9 * sequences 5,6 *;
		[X]WO9000192 (GENENCOR INC [US]) [X] 1-6,8,9 * table 1 *;
		[X]US6001964 (GAYNOR BRUCE D [US], et al) [X] 1-6,8,9 * sequence 3 *;
		[X]WO9967285 (INNOGENETICS NV [BE], et al) [X] 1-6,8,9 * table 5 *;
		[A]WO9626958 (HARVARD COLLEGE [US]) [A] * page 6, line 31 - page 8, line 10; claims 11-13,50-58 *
		[PX] - KOOLPE MITCHELL ET AL, "An ephrin mimetic peptide that selectively targets the EphA2 receptor", JOURNAL OF BIOLOGICAL CHEMISTRY, (20020925), vol. 277, no. 49, ISSN 0021-9258, pages 46974 - 46979, XP002309754 [PX] 1-27 * the entire document, particularly figure 1 and the abstract * DOI: http://dx.doi.org/10.1074/jbc.M208495200
		[A] - LIN ET AL, "The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif", JOURNAL OF BIOLOGICAL CHEMISTRY, (19990205), vol. 274, no. 6, ISSN 0021-9258, pages 3726 - 3733, XP002137902 [A] * the whole document * DOI: http://dx.doi.org/10.1074/jbc.274.6.3726
	by applicant	US4631190
		US4569789
		US4356166
		US4171563
		WO9325221
		WO9417784
		EP0613683
		- FLANAGAN, VANDERHAEGHEN, ANN REV NEUROSCI, (1998), vol. 21, pages 309 - 345
		- MANNING ET AL., TRENDS BIOCHEM SCI, (2002), vol. 27, pages 514 - 520
		- MURAI, K., PASQUALE, E., J. CELL SCI, (2003), vol. 116, pages 2823 - 2832
		- FLANAGAN, J.G., VANDERHAEGHEN, P., ANN REV NEUROSCI, (1998), vol. 21, pages 309 - 345
		- DODELET, V.C., PASQUALE, E.B., ONCOGENE, (2000), vol. 19, pages 5614 - 5619
		- YANCOPOULOS, G.D. ET AL., NATURE, (2000), vol. 407, pages 242 - 248
		- OGAWA, K. ET AL., ONCOGENE, (2000), vol. 19, pages 6043 - 6052
		- PANDEY, A. ET AL., SCIENCE, (1995), vol. 268, pages 567 - 569
		- CHENG, N. ET AL., MOL CANCER RES, (2002), vol. 1, pages 2 - 11
		- MYERS, C. ET AL., J CELL BIOL, (2000), vol. 148, pages 343 - 351
		- DANIEL, T.O. ET AL., KIDNEY INT, (1996), vol. 57, pages 73 - 81
		- HESS, A.R. ET AL., CANCER RES, (2001), vol. 61, pages 3250 - 3255
		- RUIZ, J.C., ROBERTSON, E.J., MECH DEV, (1994), vol. 46, pages 87 - 100
		- GANJU, P. ET AL., ONCOGENE, (1994), vol. 9, pages 1613 - 1624
		- BERCLAZ, G. ET AL., BIOCHEM BIOPHYS RES COMMUN, (1996), vol. 226, pages 869 - 875
		- KIYUOKAWA, E. ET AL., CANCER RES, (1994), vol. 54, pages 3645 - 3650
		- BENNETT, B.D. ET AL., PNAS USA, (1995), vol. 92, pages 1866 - 1870
		- LIU, W. ET AL., CANCER, (2002), vol. 94, pages 934 - 939
		- STEPHENSON, S. ET AL., BMC MOL BIOL, (2001), vol. 2, pages 15 - 23
		- WANG, H.U. ET AL., CELL, (1998), vol. 93, pages 741 - 753
		- GERETY, S.S. ET AL., MOL CELL, (1999), vol. 4, pages 403 - 414
		- BATTAGLIA, A.A. ET AL., NATURE NEUROSCI, (2003), vol. 6, pages 339 - 340
		- CONOVER, J.C. ET AL., NATURE NEUROSCI, (2000), vol. 3, pages 1091 - 1097
		- MURAI, K.K., PASQUALE, E.B., NEURON, (2002), vol. 33, pages 159 - 162
		- MARTIN ET AL., CANCER RES, (2000), vol. 60, pages 3218 - 3224
		- KREITMAN, PASTAN, BLOOD, (1997), vol. 90, pages 252 - 259
		- ALLAM ET AL., CANCER RES, (1997), vol. 57, pages 2615 - 2618
		- OSBORNE, CORONADO HEINSOHN, CANCER J SCI AM, (1996), vol. 2, page 175
		- MERRIFIELD, J AM CHEM SOC, (1963), vol. 85, page 2149
		- ANDREU ET AL., METH MOL BIO, (1994), vol. 35, no. 7, pages 91 - 169
		- BARKER ET AL., J MED CHEM, (1992), vol. 35, pages 2040 - 2048
		- OR ET AL., J ORG CHEM, (1991), vol. 56, pages 3146 - 3149
		- ARAP, W. ET AL., SCIENCE, (1998), vol. 279, pages 377 - 380
		- OLSON, T.A. ET AL., INT J CANCER, (1997), vol. 73, pages 865 - 870
		- ELLERBY, H.M. ET AL., NAT MED, (1999), vol. 5, pages 1032 - 1038
		- ARAP, W. ET AL., PNAS USA, (2002), vol. 99, pages 1527 - 1531
		- GERLAG, D.M. ET AL., ARTHRITIS RESEARCH, (2001), vol. 3, pages 357 - 361
		- ZANTEK, N.D. ET AL., CELL GROWTH DIFFER, (1999), vol. 10, pages 629 - 638
		- CARLES-KINCH, K. ET AL., CANCER RES, (2002), vol. 62, pages 2840 - 2847
		- VAN DER GEER, P. ET AL., ANNU REV CELL BIOL, (1994), vol. 10, pages 251 - 337
		- CELL BIOL, vol. 2, pages 62 - 69
		- ZELINSKI, D.P. ET AL., J CELL BIOCHEM, (2002), vol. 85, pages 714 - 720
		- DOHN, M. ET AL., ONCOGENE, (2001), vol. 20, pages 6503 - 6515
		- BLATTLER ET AL., BIOCHEMISTRY, (1985), vol. 24, pages 1517 - 1525
		- TICE, BIBI, Treatise on Controlled Drug Delivery, MARCEL DEKKER, (1992), pages 315 - 339
		- MIRANDA ET AL., EXP NEUROL, (1999), vol. 156, pages 218 - 222
		- WILLSON ET AL., CELL TRANSPLANTATION, (2002), vol. 11, pages 229 - 239
		- EBERHART ET AL., DEV BIOL, (2002), vol. 247, pages 89 - 101
		- DOTTORI ET AL., PNAS USA, (1998), vol. 95, pages 13248 - 13253
		- KULLANDER ET AL., NAT REV MOL CELL BIOL, (2001), vol. 3, pages 475 - 486
		- YUE ET AL., J NEUROSCI, (1999), vol. 19, pages 2090 - 2101
		- PREVOST ET AL., PNAS USA, (2002), vol. 99, pages 9219 - 9224

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p